The Chief Officers team at Cimeio Therapeutics comprises the Chief Medical Officer, Chief Financial Officer, Chief Manufacturing Officer, and Chief Scientific Officer. Together, they provide strategic leadership and oversight, ensuring the company effectively advances its gene editing, cellular, and immunotherapy treatments from research and development through to clinical application and commercialization, while managing financial health and operational efficiency.
View all